Regenxbio: 4Q Earnings Snapshot

ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Monday reported a loss of $46.2 million in its fourth quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.24.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.11 per share.

The biotechnology company posted revenue of $21.4 million in the period.

Regenxbio shares have declined 6.5% since the beginning of the year. In the final minutes of trading on Monday, shares hit $42.43, a rise of roughly 5% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RGNX at

Copyright © 2021 . All rights reserved. This website is not intended for users located within the European Economic Area.


Sign up for breaking news alerts